KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Common Equity (2016 - 2025)

Merck (MRK) has disclosed Common Equity for 17 consecutive years, with $52.6 billion as the latest value for Q4 2025.

  • Quarterly Common Equity rose 13.44% to $52.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.6 billion through Dec 2025, up 13.44% year-over-year, with the annual reading at $52.6 billion for FY2025, 13.44% up from the prior year.
  • Common Equity for Q4 2025 was $52.6 billion at Merck, up from $51.8 billion in the prior quarter.
  • The five-year high for Common Equity was $52.6 billion in Q4 2025, with the low at $27.0 billion in Q1 2021.
  • Average Common Equity over 5 years is $42.5 billion, with a median of $43.5 billion recorded in 2022.
  • The sharpest move saw Common Equity soared 51.46% in 2022, then fell 18.29% in 2023.
  • Over 5 years, Common Equity stood at $38.3 billion in 2021, then grew by 20.39% to $46.1 billion in 2022, then decreased by 18.29% to $37.6 billion in 2023, then rose by 23.22% to $46.4 billion in 2024, then grew by 13.44% to $52.6 billion in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $52.6 billion, $51.8 billion, and $49.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.